Page 20 - Devos Center News Today

The agency's decision to ease access to the drug mifepristone comes at a time when abortion rights are being increasingly restricted nationwide.

Updated December 16, 2021 at 5:08 PM ET The Food and Drug Administration has announced it will relax controversial restrictions on a heavily regulated

Baltimore Archbishop William E. Lori decried the FDA’s decision to no longer require the abortion drug mifepristone to be picked up in person.

WASHINGTON—The Food and Drug Administration (FDA) today significantly weakened longstanding safety protocols for dangerous chemical abortion pills that have been in place for more than 20 years. Melanie Israel, policy analyst in Heritage’s DeVos Center for Religion and Civil Society, released the following statement Thursday on the implications of this action:

The agency's decision to ease access to the drug mifepristone comes at a time when abortion rights are being increasingly restricted nationwide.

Before the pandemic, doctors like Nisha Verma could only prescribe abortion pills to patients who came to her clinic in person. But at least for now, the

Before the pandemic, doctors like Nisha Verma could only prescribe abortion pills to patients who came to her clinic in person. But at least for now, the

The abortion pill mifepristone was approved in 2000 but still faces layers of restrictions. Advocates want the FDA to permanently allow patients to receive the pill by mail instead of in person.

The abortion pill mifepristone was approved in 2000 but still faces layers of restrictions. Advocates want the FDA to permanently allow patients to receive the pill by mail instead of in person.

The abortion pill mifepristone was approved in 2000 but still faces layers of restrictions. Advocates want the FDA to permanently allow patients to receive the pill by mail instead of in person.